EFFECT OF THE HOMOEOPATHIC MEDICINES IN ACUTE PAI
- Conditions
- Health Condition 1: R52- Pain, unspecified
- Registration Number
- CTRI/2024/04/066301
- Lead Sponsor
- Tantia University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. All the patients presenting with acute pain.
2. Patients of all age group and both sexes.
3. Patients taking a prescription medication (NSAIDs, acetaminophen, and aspirin) episodically (or as needed) for the management of pain, agrees to discontinue its use prior to or at the Screening and Baseline Visit
4. Patients agreeing to not commence any new prescription medication for the management of pain
throughout the study
5. Patients agreeing to not commence any injection therapy for pain during the course of the study
6. Patients agreeing to not use acupuncture, biofeedback, or transcutaneous electrical nerve
stimulation (TENS) for the management of pain during the course of the study.
1. Terminally ill patients. [eg. congestive heart failure, renal failure or dialysis etc.]
2. Patients unwilling to give the consent.
3. Patients with pre-existing opiate therapy; and patients with dependencies on tobacco, alcohol, opioids, or other substances.
4. Patients with angina, bronchospasm, bronchial asthma, bronchospasm (chronic obstructive pulmonary disease and emphysema), diabetes mellitus, hyperthyroidism, fibromyalgia, or uncontrolled seizures or known hypersensitivity.
5. Anything that, in the opinion of the investigator, would place the participant at
increased risk or preclude the participant’s full compliance with or completion of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Analogue Scale (VAS) measuring pain intensityTimepoint: Visual Analogue Scale (VAS) at Baseline <br/ ><br>And After 1 week of intervention
- Secondary Outcome Measures
Name Time Method Health-related quality of life (HRQOL)Timepoint: Health-related quality of life (HRQOL) at Baseline & after 1 week of intervention